Kai Zhao

发表

Multistage Delivery Nanoparticle Facilitates Efficient CRISPR/dCas9 Activation and Tumor Growth Suppression In Vivo

Yang Liu, Zhanzhan Zhang, Linqi Shi, 2018, Advanced science.

Single-cell RNA-seq reveals RAD51AP1 as a potent mediator of EGFRvIII in human glioblastomas

C. Kang, Xing Liu, Chuan Fang, 2019, Aging.

Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway

Chuanlu Jiang, Chao Yang, Sijing Zhang, 2018, Theranostics.

Effects of combined radiosurgery and temozolomide therapy on epidermal growth factor receptor and variant III in glioblastoma multiforme

C. Kang, Chuan Fang, Yanli Tan, 2018, Oncology letters.

Siglec-15 Regulates the Inflammatory Response and Polarization of Tumor-Associated Macrophages in Pancreatic Cancer by Inhibiting the cGAS-STING Signaling Pathway

Kai Zhao, Rongxuan Zhu, Defei Hong, 2022, Oxidative medicine and cellular longevity.

Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide

C. Nimsky, H. Raifer, A. Neubauer, 2022, Biomedicines.

RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner

Chao Yang, C. Kang, Hua You, 2019, Cell Death & Disease.

EGFR/c-myc axis regulates TGFβ/Hippo/Notch pathway via epigenetic silencing miR-524 in gliomas.

Kai Huang, Chao Yang, C. Kang, 2017, Cancer letters.

Identification of Dysregulated microRNAs in Glioblastoma Stem-like Cells

C. Nimsky, Susanne Stei, Kai Zhao, 2023, Brain sciences.

A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep

Chao Yang, C. Kang, Yu Ren, 2019, Theranostics.

TRAF4 maintains deubiquitination of Caveolin-1 to drive glioblastoma stemness and Temozolomide resistance.

N. Lu, Jinming Yang, Kai Zhao, 2022, Cancer research.